| 2011 | 18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer. | JOURNAL OF SURGICAL ONCOLOGY |
| 2007 | A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and ...
| CANCER RESEARCH AND TREATMENT |
| 2021 | A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer | INVESTIGATIONAL NEW DRUGS |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | INVESTIGATIONAL NEW DRUGS |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | INVESTIGATIONAL NEW DRUGS |
| 2012 | A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy | INVESTIGATIONAL NEW DRUGS |
| 2012 | A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy | INVESTIGATIONAL NEW DRUGS |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2020 | A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2016 | A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis | RADIOTHERAPY AND ONCOLOGY |
| 2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
| 2006 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
| BRITISH JOURNAL OF CANCER |
| 2005 | A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
| 2015 | A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2020 | A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases | CLINICAL COLORECTAL CANCER |
| 2017 | ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition | BIOCHEMICAL PHARMACOLOGY |
| 2010 | Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial? | INTERNATIONAL JOURNAL OF COLORECTAL DISEASE |
| 2012 | Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.
| BMC CANCER |
| 2013 | Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications | INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS |
| 2021 | Association between Fusobacterium nucleatum and patient prognosis in metastatic colon cancer
| SCIENTIFIC REPORTS |
| 2009 | Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
| ANNALS OF ONCOLOGY |
| 2005 | Bax, a predictive marker for therapeutic response to ptroperative chemoradiotherapy in patents with rectal carcinoma | HUMAN PATHOLOGY |
| 2016 | Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| YONSEI MEDICAL JOURNAL |
| 2018 | BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2016 | Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis | DISEASES OF THE COLON & RECTUM |
| 2011 | Brain metastases from colorectal carcinoma: prognostic factors and outcome | JOURNAL OF NEURO-ONCOLOGY |
| 2014 | Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer? | DISEASES OF THE COLON & RECTUM |
| 2008 | Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2016 | Cardiopulmonary fitness, adiponectin, chemerin associated fasting insulin level in colorectal cancer patients. | SUPPORTIVE CARE IN CANCER |
| 2007 | Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases | ONKOLOGIE |
| 2007 | Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy | ACTA ONCOLOGICA |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| ONCOLOGY LETTERS |
| 2013 | Changing treatment patterns in elderly patients with resectable colon cancer | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
| 2008 | Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
| BMC CANCER |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2013 | Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent | INVESTIGATIONAL NEW DRUGS |
| 2016 | Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2020 | Clinical features and KRAS mutation in colorectal cancer with bone metastasis
| SCIENTIFIC REPORTS |
| 2015 | Clinical implications from a single-center study of colorectal adenocarcinoma in transplant recipients | ONCOLOGY |
| 2020 | Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection | ANNALS OF SURGICAL ONCOLOGY |
| 2014 | Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Clinical value of ezrin expression in primary osteosarcoma
| CANCER RESEARCH AND TREATMENT |
| 2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| CANCER RESEARCH AND TREATMENT |
| 2013 | Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells. | ANTICANCER RESEARCH |
| 2012 | Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2005 | Comparative Analysis of the Effects of Belly Board and Bladder Distension in Postoperative Radiotherapy of Rectal Cancer Patients | STRAHLENTHERAPIE UND ONKOLOGIE |
| 2009 | Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2018 | CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
| YONSEI MEDICAL JOURNAL |
| 2022 | Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
| FRONTIERS IN ONCOLOGY |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2014 | Differential Expression of CD133 Based on Microsatellite Instability Status in Human Colorectal Cancer | MOLECULAR CARCINOGENESIS |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| ANNALS OF SURGERY |
| 2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| CANCER |
| 2015 | Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2016 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
| CANCER RESEARCH AND TREATMENT |
| 2011 | Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer | SUPPORTIVE CARE IN CANCER |
| 2023 | Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon Cancer | CLINICAL COLORECTAL CANCER |
